Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-01

FDA Approved: POSACONAZOLE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for posaconazole from Lupin Pharmaceuticals, enabling generic availability of the antifungal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POSACONAZOLE (POSACONAZOLE)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)